ICU Medical Inc
NASDAQ:ICUI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
84.39
183.83
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ICUI stock under the Base Case scenario is 190.76 USD. Compared to the current market price of 168.46 USD, ICU Medical Inc is Undervalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
ICU Medical Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ICUI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
ICU Medical Inc
Balance Sheet Decomposition
ICU Medical Inc
Current Assets | 1.3B |
Cash & Short-Term Investments | 312.5m |
Receivables | 177.7m |
Other Current Assets | 767.8m |
Non-Current Assets | 3B |
Long-Term Investments | 3.1m |
PP&E | 658.5m |
Intangibles | 2.3B |
Other Non-Current Assets | 121.3m |
Current Liabilities | 549.6m |
Accounts Payable | 168.6m |
Accrued Liabilities | 297.8m |
Other Current Liabilities | 83.2m |
Non-Current Liabilities | 1.7B |
Long-Term Debt | 1.5B |
Other Non-Current Liabilities | 161.3m |
Earnings Waterfall
ICU Medical Inc
Revenue
|
2.3B
USD
|
Cost of Revenue
|
-1.6B
USD
|
Gross Profit
|
769.1m
USD
|
Operating Expenses
|
-715.2m
USD
|
Operating Income
|
53.9m
USD
|
Other Expenses
|
-164.9m
USD
|
Net Income
|
-111m
USD
|
Free Cash Flow Analysis
ICU Medical Inc
USD | |
Free Cash Flow | USD |
In Q3 2024, ICU Medical reported revenues of $580 million, reflecting a 7% increase year-over-year. The company achieved an adjusted EBITDA of $95 million and an EPS of $1.59. Notably, it experienced improved gross margins due to operational efficiencies, expected to maintain between 36-37% in Q4. ICU Medical anticipates full-year adjusted EBITDA between $355 million and $365 million, revising EPS guidance to $5.40-$5.70 per share. A significant joint venture with Otsuka Pharmaceutical aims to enhance IV Solutions, expected to improve operational efficiency and market position, although ICU will deconsolidate related revenue and recognize proportional net earnings.
What is Earnings Call?
ICUI Profitability Score
Profitability Due Diligence
ICU Medical Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
ICU Medical Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
ICUI Solvency Score
Solvency Due Diligence
ICU Medical Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
ICU Medical Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ICUI Price Targets Summary
ICU Medical Inc
According to Wall Street analysts, the average 1-year price target for ICUI is 212.77 USD with a low forecast of 202 USD and a high forecast of 236.25 USD.
Dividends
Current shareholder yield for ICUI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ICUI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 8,500 full-time employees. The firm provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The firm's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. The company offers blood pressure monitoring system.
Contact
IPO
Employees
Officers
The intrinsic value of one ICUI stock under the Base Case scenario is 190.76 USD.
Compared to the current market price of 168.46 USD, ICU Medical Inc is Undervalued by 12%.